Company Overview

INOVIQ Ltd (ASX:IIQ) is a leader in exosome technology advancing next-generation diagnostics and therapeutics that transform cancer care. Our product portfolio includes commercial-stage exosome isolation products, clinical-stage diagnostics for ovarian and breast cancers, and a cutting-edge preclinical CAR-exosome therapeutic program for solid tumours. INOVIQ is shaping the future of cancer detection and treatment to improve patient outcomes.

INOVIQ’s headquarters are based in Melbourne, Australia, with a dedicated team of highly skilled employees. Our expertise spans corporate, scientific, and clinical expertise, across exosome technology, diagnostics, and cell therapy.

Our Mission

INOVIQ's mission is to transform patient lives through earlier cancer detection and more effective treatments, powered by proprietary exosome technologies.